I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Clavio, Marino
27
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Post-Transplant Nivolumab Plus Unselected Autologous Lympho..:
Guolo, Fabio
;
Minetto, Paola
;
Pesce, Silvia
...
info:eu-repo/semantics/altIdentifier/pmid/34804039. , 2021
Link:
https://hdl.handle.net/1..
?
2
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salv..:
Manconi, Lorenzo
;
Coviello, Elisa
;
Canale, Filippo
...
info:eu-repo/semantics/altIdentifier/pmid/31480933. , 2020
Link:
http://hdl.handle.net/11..
?
3
Gene expression profile predicts response to the combinatio..:
Visani, Giuseppe
;
Loscocco, Federica
;
Dennis, Mike
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594404/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
4
Fludarabine, High-Dose Cytarabine and Idarubicin-Based Indu..:
Minetto, Paola
;
Candoni, Anna
;
Guolo, Fabio
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796342/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
5
CPX-351 treatment in secondary acute myeloblastic leukemia ..:
Guolo, Fabio
;
Fianchi, Luana
;
Minetto, Paola
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538937/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
6
SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Ea..:
Mossuto, Sandra
;
Attardi, Enrico
;
Alesiani, Francesco
...
info:eu-repo/semantics/altIdentifier/pmid/33062948. , 2020
Link:
http://hdl.handle.net/23..
?
7
The new small tyrosine kinase inhibitor ARQ531 targets acut..:
Soncini, Debora
;
Orecchioni, Stefania
;
Ruberti, Samantha
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556675/. , 2020
Link:
http://www.ncbi.nlm.nih...
?
8
The new small tyrosine-kinase inhibitor ARQ531 targets acut..:
Soncini, Debora
;
Orecchioni, Stefania
;
Ruberti, Samantha
...
info:eu-repo/semantics/altIdentifier/pmid/31624110. , 2019
Link:
http://hdl.handle.net/24..
?
9
Longitudinal minimal residual disease (MRD) evaluation in a..:
Guolo, Fabio
;
Minetto, Paola
;
Clavio, Marino
...
info:eu-repo/semantics/altIdentifier/pmid/31348524. , 2019
Link:
http://hdl.handle.net/11..
?
10
The new small tyrosine-kinase inhibitor ARQ531 targets acut..:
Soncini, Debora
;
Orecchioni, Stefania
;
Ruberti, Samantha
...
info:eu-repo/semantics/altIdentifier/pmid/31624110. , 2019
Link:
http://hdl.handle.net/11..
?
11
Effects of different doses of erythropoietin in patients wi..:
Balleari, Enrico
;
Filiberti, Rosa Angela
;
Salvetti, Chiara
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912022/. , 2019
Link:
http://www.ncbi.nlm.nih...
?
12
Prompt detection of L-asparaginase inactivation is crucial ..:
Guolo, Fabio
;
Ferrari, Mariella
;
Minetto, Paola
...
info:eu-repo/semantics/altIdentifier/pmid/29052244. , 2018
Link:
http://hdl.handle.net/11..
?
13
Combining flow cytometry and WT1 assessment improves the pr..:
Guolo, Fabio
;
Minetto, Paola
;
Clavio, Marino
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685236/. , 2017
Link:
http://www.ncbi.nlm.nih...
?
14
Clinical and experimental efficacy of gemtuzumab ozogamicin..:
Gottardi, Michele
;
Mosna, Federico
;
De Angeli, Sergio
...
info:eu-repo/semantics/altIdentifier/pmid/29071049. , 2017
Link:
http://hdl.handle.net/11..
?
15
Clinical and experimental efficacy of gemtuzumab ozogamicin..:
Gottardi, Michele
;
Mosna, Federico
;
de Angeli, Sergio
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641839/. , 2017
Link:
http://www.ncbi.nlm.nih...
1-15